PROCEPT BioRobotics Corporation, a surgical robotics company, focuses on developing transformative solutions in urology in the United States and internationally. The company develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally invasive urologic surgery focusing on treating benign prostatic hyperplasia. It also provides HYDROS Robotic System, which provides Aquablation therapy image-guided robotic therapy to treat males suffering from lower urinary tract symptoms due to benign prostatic hyperplasia. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in San Jose, California.

Market Cap	$1.85B	P/E Ratio	N/A
52W High	$100.89	52W Low	$27.84
Div Yield	N/A	Payout Ratio	N/A
EPS Growth 3Y	21.6%	52W Position	2.8%
Overall Score	44	Value Score	55
Quality Score	--	Technical Score	33

EPS Current Est	$-1.51	EPS Next Est	$-1.06
EPS Growth Est	N/A	DPS Growth 3Y	N/A

	A	B	C	D
1	Symbol	Price	Change	Volume
2	PRCT	$29.86	+7.06%	2.52M
3
4
5

	A	B	C	D
1	Symbol	Price	Change	Vol
2	PRCT	$29.86	+7.1%	2.52M
3
4
5
6

PRCT

PRCT

Key Metrics Overview

Growth Analysis

Revenue (5Y)

EBITDA (5Y)

Get PROCEPT BioRobotics Corporation Data in Excel

Get PROCEPT BioRobotics Corporation Data in Excel